Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.65 |
| ▸ | CA6 | P23280 | 5/20 | 0.65 |
| ▸ | CA7 | P43166 | 5/20 | 0.65 |
| ▸ | CA9 | Q16790 | 5/20 | 0.65 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.65 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.65 |
| ▸ | CA2 | P00918 | 4/20 | 0.65 |
| ▸ | CA4 | P22748 | 4/20 | 0.65 |
| ▸ | CA5A | P35218 | 4/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.65 |
| ▸ | CA3 | P07451 | 3/20 | 0.65 |
| ▸ | F13A1 | P00488 | 2/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.65 |
| ▸ | THPO | P40225 | 2/20 | 0.65 |
| ▸ | CA1 | P00915 | 2/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.65 |
| ▸ | PKM | P14618 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | MTOR | P42345 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 3/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8065129 | 0.92 | CA12 (0.68) | CA12CA6CA7CA9CA14 | |
| SCHEMBL7207430 | 0.86 | CA12 (0.68) | CA12CA6CA7CA9CA14 | |
| Trientine SCHEMBL15016070 | 0.86 | CA12 (0.77) | CA12CA6CA7CA9CA14 | |
| SCHEMBL3992768 | 0.86 | CA12 (0.87) | CA12CA6CA7CA9CA14 | |
| SCHEMBL3998692 | 0.86 | CA12 (0.87) | CA12CA6CA7CA9CA14 | |
| SCHEMBL16281062 | 0.86 | CA12 (0.87) | CA12CA6CA7CA9CA14 | |
| SCHEMBL9182483 | 0.86 | CA12 (0.87) | CA12CA6CA7CA9CA14 | |
| SCHEMBL20261145 | 0.86 | CA12 (0.87) | CA12CA6CA7CA9CA14 | |
| SCHEMBL7096452 | 0.86 | CA12 (0.87) | CA12CA6CA7CA9CA14 | |
| SCHEMBL21388272 | 0.86 | CA12 (0.87) | CA12CA6CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7452845-B2 | Mesoporous organic-inorganic hybrid materials for separating gases | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2008-11-18 | — | — | US | claimed |
| EP-1370563-B1 | MESOPOROUS ORGANIC-INORGANIC HYBRID MATERIALS FOR SEPARATING GASES | CENTRE NAT RECH SCIENT (FR) | 2006-09-06 | — | — | EP | claimed |
| US-20040122250-A1 | Mesoporous organic-inorganic hybrid materials for separating gases | CENTRE NATIONAL DE LA RECHERCHE-SCIENTIFIQUE (FR) | 2004-06-24 | — | — | US | claimed |
| US-7452845-B2 | Mesoporous organic-inorganic hybrid materials for separating gases | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2008-11-18 | — | — | US | disclosed |
| EP-1370563-B1 | MESOPOROUS ORGANIC-INORGANIC HYBRID MATERIALS FOR SEPARATING GASES | CENTRE NAT RECH SCIENT (FR) | 2006-09-06 | — | — | EP | disclosed |
| US-20040122250-A1 | Mesoporous organic-inorganic hybrid materials for separating gases | CENTRE NATIONAL DE LA RECHERCHE-SCIENTIFIQUE (FR) | 2004-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040122250-A1 | Mesoporous organic-inorganic hybrid materials for separating gases | SCO2, IPO9, IPO4 | CA12 174/4885CA6 83/4885CA7 87/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.